DNA methylation of KEAP1 has been more frequently studied than NFE2L2 across multiple cancer models, revealing distinct methylation patterns at KEAP1 promoter region when comparing normal and tumor lung tissues [81,82,83]. This evidence concerns the gene NFE2L2 and cancer.